Raras
Buscar doenças, sintomas, genes...
Uveíte posterior
ORPHA:280892DOENÇA RARA

A uveíte é um conjunto de doenças nos olhos, decorrente de uma inflamação da úvea, que é formada pela íris, corpo ciliar e coróide.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Inflamação da camada vascular do olho (úvea) na parte posterior, afetando a retina e a coroide. Pode causar visão turva, manchas e dor ocular, com potencial para perda visual.

Pesquisas ativas
7 ensaios
94 total registrados no ClinicalTrials.gov
Publicações científicas
2.010 artigos
Último publicado: 2026 Apr 17
Medicamentos
5 registrados
DEXAMETHASONE, PREDNISONE, PREDNISOLONE

Tem tratamento?

5 medicamentos registrados
Ver detalhes, fases e interações →
DEXAMETHASONEPREDNISONEPREDNISOLONEDEXAMETHASONE SODIUM PHOSPHATEBEVACIZUMAB

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.010PubMed
Últimos 10 anos200publicações
Pico2025127 papers
Linha do tempo
2026Hoje · 2026🧪 1996Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado5
3Fase 34
2Fase 26
·Pré-clínico10
Medicamentos catalogadosEnsaios clínicos· 5 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Uveíte posterior

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

94 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
NCT06431373 · A Study of Brepocitinib in Adults With Active, Non-Infectiou…Ativo
PHASE3
NCT07262437 · Targeting Immunosuppressive Treatment for Non-infectious Uve…Ativo
NA
NCT05322070 · Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the T…Ativo
PHASE4
NCT07423442 · Frequency and Intensity of Inflammatory Relapses in Patients…Em breve
NCT06743906 · Role of OCT & OCT Angiography in Patients With Posterior at …Em breve
NCT02931175 · ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)Concluído
PHASE2
NCT05523765 · A Study of Brepocitinib in Adults With Active Non-Infectious…Concluído
PHASE2
NCT05101928 · Ozurdex Monotherapy TrialCancelado
PHASE4
NCT05384249 · Phase 2b Pivotal Study of Izokibep in Non-infectious, Interm…Encerrado
PHASE2
NCT05070728 · Safety and Efficacy of an Injectable Fluocinolone Acetonide …Encerrado
PHASE3
NCT06613919 · Six-months Versus Nine-months ATT for Ocular TBConcluído
PHASE4
NCT05953688 · POC Study to Evaluate the Efficacy and Safety of ESK-001 in …Encerrado
PHASE2
NCT00499551 · A Phase I/IIa Study for the Treatment of Uveitis With Iontop…Cancelado
PHASE1, PHASE2
NCT01280669 · Intravitreal Sirolimus as Therapeutic Approach to UveitisCancelado
PHASE2
NCT06085079 · Ixekizumab for the Management of Refractory Non-Infectious U…UNKNOWN
PHASE4
NCT00539370 · Human Samples and Data RepositoryEncerrado
NCT03753893 · Ocular Manifestations in Rheumatic DiseasesConcluído
NCT03656692 · Safety and Effectiveness of Acthar Gel for Inflammation of t…Encerrado
PHASE4
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.089 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.089

#1

Are the SUN Criteria Sufficient for Tubercular Uveitis? Findings From a Multinational Registry Study.

Investigative ophthalmology &amp; visual science2026 Jan 05

The Standardization of Uveitis Nomenclature (SUN) criteria were introduced in 2021 to standardize the classification of uveitis subtypes. We evaluated the real-world applicability of these criteria for tubercular uveitis (TBU) using a computational definition mapped to the Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) registry. This observational retrospective cross-sectional study analyzed real-world baseline data from 372 clinician-diagnosed TBU cases within the multinational OASIS registry, all collected from 17 tertiary centers across 8 countries: India, Nepal, Indonesia, Switzerland, Ethiopia, Colombia, Argentina, and Chile. We mapped the SUN criteria to corresponding variables in the OASIS registry, and Boolean operators were used to generate a computational definition for TBU. The sensitivity of the SUN criteria in capturing clinician-diagnosed cases of TBU was evaluated. The SUN criteria identified 15.9% (n = 59) of clinician-diagnosed TBU cases at baseline. Criterion f2 (evidence of TB infection) was met in 70.7% of cases (n = 263), and criterion f1 (TBU-compatible uveitic syndrome) was satisfied in 24.5% of cases (n = 91). Exclusion criterion successfully identified 99.5% of cases (n = 370). By country and anatomical location, cases in India and those with posterior uveitis had the highest concordance at 19.8% (n = 39) and 21.8% (n = 44), respectively. Bilateral TBU was more likely to satisfy the SUN criteria (P = 0.049). SUN classification criteria demonstrated low sensitivity for real-world TBU diagnosis at baseline, which may limit the number of cases available for enrollment in research studies. Further diagnostic refinement, clearer definition of application context, and longitudinal validation are needed to generate diagnostic criteria for clinical application.

#2

A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitis.

International journal of pharmaceutics2026 Mar 21

Uveitis is a leading cause of global vision loss. Local corticosteroid therapy, notably intravitreal or suprachoroidal triamcinolone injections, remains central to its clinical management. However, frequent intraocular injections and poor patient compliance substantially increase the risk of complications such as endophthalmitis. Although eye drops represent a more attractive noninvasive alternative, their efficacy in treating posterior segment diseases is severely limited by ocular defense mechanisms, resulting in extremely low bioavailability (<5%). To address these challenges, we propose a strategy combining prodrug modification with physical permeation enhancement. Triamcinolone acetonide was converted into an ester prodrug and formulated into a nanoemulsion using a reverse emulsification method. When coupled with iontophoresis, this system significantly improved drug delivery efficiency to the posterior segment of the eye. In a rabbit model of experimental autoimmune uveitis (EAU), a single administration of triamcinolone acetonide palmitate nanoemulsion (TAP-NE) sustained anti-inflammatory effects for up to 14 days. It significantly downregulated inflammatory cytokines including IL‑6 and IL‑17, and alleviated uveitis by suppressing the activation of retinal macroglia (GFAP) and microglia (IBA‑1). Furthermore, it maintained blood-retinal barrier (BRB) integrity, thereby preventing subsequent intraocular damage. Safety evaluations confirmed its favorable biocompatibility, with no detectable ocular irritation or tissue injury. The TAP-NE system combined with iontophoretic delivery developed in this study offers a novel strategy for addressing uveitis as well as other ocular conditions associated with inflammatory processes.

#3

Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10.

American journal of ophthalmology2026 Mar 18

To develop imaging-based measures for disease assessment in non-infectious posterior uveitis (NIPU). A mixed-methods design, beginning with a review of previously developed imaging recommendations formulated by separate subcommittees of the Multimodal Imaging in Uveitis (MUV) initiative, followed by a structured consensus process using the Nominal Group Technique (NGT), facilitated by an independent expert committee. An expert committee reviewed and extracted all consensus-based imaging recommendations by the MUV subcommittee manuscripts focused on five major NIPU entities. The primary objective was to categorize imaging features as suggestive of active disease (SAD), suggestive of inactive disease (SID), or equivocal. This process was conducted using the NGT to reach consensus-based imaging measures. These recommendations were further voted upon by members of the full task force. A total of 49 imaging statements were deliberated using two rounds of NGT and independent voting. For the five included diseases, a total of 21 statements qualified as features of SAD, whereas 12 statements were classified as SID. The remaining 16 statements were categorized as equivocal features, that need further investigation to determine whether the disease is active. This study builds upon the multinational efforts of the MUV initiative to extend the Standardization of Uveitis Nomenclature (SUN) work through the integration of additional multimodal imaging information. By defining clear imaging-based outcome measures for NIPU, it establishes a structured framework supporting objective disease assessment. These standardized imaging measures are expected to enhance the utility of multimodal imaging in both routine uveitis care and future clinical trials.

#4

NON-INFECTIOUS POSTERIOR UVEITIDES - Atypicals, Variants, and Masquerades: the jungle of differential diagnosis.

American journal of ophthalmology2026 Mar 18

Non-infectious posterior and panuveitides (NIPUs) comprise a heterogeneous group of inflammatory disorders of the outer retina and choroid, historically referred to as "white dot syndromes." Recent consensus efforts by the Multimodal Imaging in Uveitis (MUV) Task Force have established standardized diagnostic criteria for the major NIPUs, including multiple evanescent white dot syndrome (MEWDS), multifocal choroiditis and panuveitis/punctate inner choroiditis (MFCPU/PIC), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), serpiginous choroiditis, and birdshot chorioretinopathy (BSCR). Nevertheless, a substantial proportion of cases deviate from classical presentations and fall into diagnostic "grey zones", blurring boundaries between diseases entities and complicating both differential diagnosis and management. This review aims to describe the broad spectrum of atypical, variant, and secondary forms of NIPUs as well as masquerade syndromes. Atypical MEWDS includes bilateral presentations or complicated courses, while MFCPU/PIC with outer retinal atrophy emerges as a notable entity with unclear therapeutic implications. Inflammatory reactions resembling both MEWDS and MFCPU/PIC may also occur as secondary phenomena, triggered by other chorioretinal disorders, most notably inherited retinal diseases (IRDs). Placoid chorioretinopathies, including APMPPE, persistent placoid maculopathy, serpiginous choroiditis, and relentless placoid chorioretinitis, are often distinguished only a posteriori based on disease course, but likely represent a continuum of disorders unified by choroidal ischemia. Atypical presentations of BSCR may feature extensive outer retinal damage, mimicking IRDs. Equally important is the consideration of masquerade syndromes in all suspected cases of NIPUs, as they can present with similar features yet require entirely different treatments. Infectious masquerades include tuberculosis-associated serpiginous-like choroiditis, acute syphilitic posterior placoid chorioretinopathy, and West Nile virus chorioretinitis, whereas vitreoretinal lymphoma is the most frequent neoplastic masquerade. In conclusion, integrating clinical context with high-quality multimodal imaging remains essential to navigate the jungle of differential diagnosis in NIPUs, while future studies should aim to link imaging phenotypes with immune and molecular biomarkers to refine classification and guide targeted therapies.

#5

Combined PCR Positivity for Mycobacterium tuberculosis Complex and Nontuberculous Mycobacterium Species in Patients Treated for Tubercular Panuveitis.

Ocular immunology and inflammation2026 Mar 13

Intraocular dual infection by Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) is rarely reported. This study describes the clinical features, aetiology, and treatment outcomes of patients with dual infection from MTBC and NTM-related uveitis. A retrospective study was conducted on 146 clinically suspected tubercular uveitis (TBU) patients who underwent diagnostic or therapeutic pars plana vitrectomy as plan of laboratory diagnosis-based management between June 2023 and December 2024. Undiluted vitreous samples were analysed with nested MTBC-NTM multiplex real-time PCR assay kit. Six out of 146 patients (4.11%) were found infected with dual infection from MTBC and NTM. All six cases showed severe clinical presentation characterised by bilateral panuveitis (5/6 patients), with significant structural sequelae. Optic atrophy was universal and occurred more frequently than in isolated TBU, while complicated cataract and hypotony-related maculopathy were also common. Despite the dual etiology, all patients achieved inflammatory resolution and visual recovery (mean BCVA improving from 20/400 to 20/100) following standard anti-tubercular therapy (ATT) and corticosteroids, with no recurrence during follow-up. Concurrent MTBC and NTM infection drives a distinct, aggressive form of panuveitis characterized by optic nerve pallor, anterior segment complications of complicated cataract or uveitic membranes and maculopathy. Despite this severity, standard ATT remained an effective first-line strategy, likely either due to therapeutic cross-coverage against NTM or MTBC being the primary driver of uveitis in the present study. The concurrent positivity also highlights the need for vitreous molecular profiling and further research in co-infections in infectious posterior uveitis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC372 artigos no totalmostrando 198

2026

A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitis.

International journal of pharmaceutics
2026

Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10.

American journal of ophthalmology
2026

NON-INFECTIOUS POSTERIOR UVEITIDES - Atypicals, Variants, and Masquerades: the jungle of differential diagnosis.

American journal of ophthalmology
2026

The Multimodal Imaging in Uveitis Virtual Special Issue.

American journal of ophthalmology
2026

Combined PCR Positivity for Mycobacterium tuberculosis Complex and Nontuberculous Mycobacterium Species in Patients Treated for Tubercular Panuveitis.

Ocular immunology and inflammation
2026

Tubercular chorioretinitis mimicking sarcoidosis in a patient with celiac disease and erythema nodosum: A case report.

World journal of clinical cases
2026

Ocular manifestations of STAT3 gain-of-function syndrome: A case of papillitis, retinitis, and retinal vasculitis.

American journal of ophthalmology case reports
2026

Ocular syphilis: Clinical characteristics, HIV status, and outcomes in a 10-year case series from Türkiye.

International journal of STD &amp; AIDS
2026

Resurgence of Ocular Syphilis: HIV Co-Infection, Clinical Manifestations, and High-Risk Sexual Behaviour in an Indonesian Cohort.

Ocular immunology and inflammation
2026

Immunology of Uveitis - From Bench to Bedside.

Klinische Monatsblatter fur Augenheilkunde
2026

Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy.

Ocular immunology and inflammation
2026

Chasing shadows: case series of six posterior segment manifestations of ocular tuberculosis.

AME case reports
2026

Beyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathy.

Eye (London, England)
2026

The Spectrum of Uveitis and Retinal Vasculitis in Systemic Sclerosis: A Case Series.

Ocular immunology and inflammation
2026

Birdshot Chorioretinopathy in a Patient of Filipino Ancestry: A Case Report.

Cureus
2026

[Ocular toxoplasmosis in adults : Refresher course].

Die Ophthalmologie
2025

Paracentral Acute Middle Maculopathy Associated With Dengue Fever.

Cureus
2026

Causes of Visual Loss in Uveitis: A Retrospective Study at a Tertiary Referral Centre.

Cureus
2026

The protein-protein interaction network analysis in idiopathic posterior uveitis.

Indian journal of ophthalmology
2026

Ocular findings in patients with lyme disease: a systematic review and meta-analysis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2026

Are the SUN Criteria Sufficient for Tubercular Uveitis? Findings From a Multinational Registry Study.

Investigative ophthalmology &amp; visual science
2026

Noncancerous Monogenic Mimics of Noninfectious Posterior Uveitis.

American journal of ophthalmology
2026

Systemic immunosuppressive therapy in idiopathic non-infectious uveitis and scleritis: disease remission, discontinuation, and relapse patterns.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Intraocular Coinfection by Toxoplasma gondii and EBV Possibly Transmitted Through Unpasteurized Goat Milk in an Immunocompetent Patient: A Case Report.

Pathogens (Basel, Switzerland)
2026

Epidemiological and clinical profiles of ocular involvement in rickettsiosis in southern Tunisia.

Journal francais d'ophtalmologie
2025

The Evolution of Artificial Intelligence in Ocular Toxoplasmosis Detection: A Scoping Review on Diagnostic Models, Data Challenges, and Future Directions.

Infectious disease reports
2026

Birdshot Chorioretinopathy with Double-Layer Sign and Choroidal Neovascularization: A Single-Centre Analysis.

Ocular immunology and inflammation
2025

Interpretable multi-model deep learning framework for automated four-class diagnosis of ocular toxoplasmosis using fundus imaging.

Scientific reports
2025

Structural Retinal Analysis in Toxoplasmic Retinochoroiditis: OCT Follow-Up with Three-Dimensional Reconstruction.

Diagnostics (Basel, Switzerland)
2025

Opposing pathophysiological concepts in multiple evanescent white dot syndrome: The great MEWDS schism.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2025

Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial.

Seminars in ophthalmology
2025

Intraocular inflammation following aflibercept 8 mg: real-world data from a multicentre retrospective observational study.

International journal of retina and vitreous
2026

Clinical Profile, Management and Visual Outcomes in Patients with Sarcoid Posterior Uveitis.

Ocular immunology and inflammation
2025

Progressive Subretinal Fibrosis and Uveitis Associated with Hodgkin Lymphoma.

Case reports in ophthalmology
2025

Intraocular Tuberculosis: Current Insights and Emerging Therapeutic Paradigms.

Seminars in ophthalmology
2025

Pyogranulomatous endophthalmitis and posterior uveitis in a crested capuchin (Sapajus robustus) with systemic Paracoccidioides brasiliensis infection.

Veterinary research communications
2025

Ocular Manifestations of Pediatric Behçet's Disease.

Clinical medicine &amp; research
2025

Hyperreflective Choroidal Foci: A Comprehensive Review.

Journal of ophthalmic &amp; vision research
2025

Resurgence of Acquired Syphilitic Uveitis: Characteristics, Challenges and Outcomes.

Ocular immunology and inflammation
2026

Presumed Ocular Tuberculosis: Insights from an Egyptian Cohort.

Ocular immunology and inflammation
2025

Repository Corticotropin Therapy for Refractory Noninfectious Inflammatory Ocular Diseases.

Journal of clinical medicine
2025

Atypical Presentations and Molecular Diagnosis of Ocular Bartonellosis.

International journal of molecular sciences
2026

Management of uveitic and chorioretinal conditions in pregnancy.

Eye (London, England)
2025

Serum Concentrations of Th1, Th2 and Treg-Associated Cytokines in Patients With Ocular Toxoplasmosis.

Parasite immunology
2025

Clinical utility of ultra-widefield indocyanine green angiography in posterior uveitis.

Journal francais d'ophtalmologie
2025

Adalimumab in non-infectious uveitis, towards a real-world therapeutic paradigm beyond inflammation control: A multicenter cross-sectional study.

Journal of ophthalmic inflammation and infection
2026

Isolated Immunoglobulin G4-Related Uveitis Diagnosed by Choroidal Biopsy.

Ophthalmic surgery, lasers &amp; imaging retina
2026

Clinical and Organizational Determinants of a Frequently Delayed Diagnosis of Ocular Syphilis in a French Referral Center.

American journal of ophthalmology
2025

Self-assembled rapamycin prodrug nanoparticles for posterior segment targeting and effective treatment of experimental uveitis.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2026

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial.

Ophthalmology
2026

Nonmydriatic Ocular Fundus Imaging on Consecutive Patients Seeking Treatment at a General Emergency Department with Vision Symptoms.

Ophthalmology
2026

Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the Treatment of Noninfectious Uveitis: A Multicenter Study.

Ophthalmology
2025

Treatment With Remdesivir Alone or in Combination With GS-441524 in Cats With Ocular Involvement of Feline Infectious Peritonitis: An Observational Case Series.

Journal of veterinary internal medicine
2025

Role of Fundus Autofluorescence in Candida Chorioretinitis: Insights from a Clinical Case.

Ocular immunology and inflammation
2025

The relationship between retinal vascular tortuosity and retinal vasculitis.

Journal of ophthalmic inflammation and infection
2025

Syphilis and the Eye: Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Paradigms.

Pathogens (Basel, Switzerland)
2025

Long-term management of recurrent uveitis associated with autoimmune lymphoproliferative syndrome.

Journal of ophthalmic inflammation and infection
2025

Common data elements for observational studies in ocular toxoplasmosis: a Delphi consensus.

Journal of ophthalmic inflammation and infection
2025

Safety and efficacy profile of the fluocinolone acetonide implant in non-infectious uveitic macular edema: 5-year follow-up.

Archivos de la Sociedad Espanola de Oftalmologia
2025

Controversy and consensus on the management of ocular toxoplasmosis: A joint statement by the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII), the Asia-Pacific Vitreo-Retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and The Infectious Uveitis Treatment Algorithm Network (TITAN) Group.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2026

MULTIMODAL IMAGING AND LONG-TERM TREATMENT OUTCOMES OF RELENTLESS PLACOID CHORIORETINITIS.

Retina (Philadelphia, Pa.)
2025

Specific Skin Lesions of Sarcoidosis in the Diagnosis of Ocular Sarcoidosis.

Ocular immunology and inflammation
2025

Risk Factors for Development of Uveitis and Cystoid Macular Edema After Cataract Surgery.

Ocular immunology and inflammation
2025

Prevalence and Prognosis of Glaucoma/Elevated Intraocular Pressure in Patients with Uveitis.

Turkish journal of ophthalmology
2025

Are dexamethasone implants a safe and effective breakthrough in uveitis treatment? A systematic review and meta-analysis.

Steroids
2025

The causal relationship between uveitis and psoriatic arthritis: A bidirectional Mendelian randomisation study.

Indian journal of dermatology, venereology and leprology
2025

Demographic and Clinical Characteristics of Pediatric Uveitis Cases from a Referral Center in Turkey.

Ocular immunology and inflammation
2025

Type 1 inflammatory choroidal neovascular membrane in a case of viral uveitis - a case report.

International journal of surgery case reports
2025

Minimum Imaging Sets for Diagnosis, Activity Assessment, and Complications in Noninfectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Task Force Report 9.

American journal of ophthalmology
2025

Correlation Between Optical Coherence Tomography (OCT) and Serum Indirect Immunofluorescence Findings in a Case of Cancer Associated Retinopathy (CAR) Masquerading as White Dot Syndrome.

Ocular immunology and inflammation
2025

Epidemiology and Clinical Features of Uveitis in Southwestern Japan: Laterality and Long-Term Visual Prognosis Based on the Anatomical and Epidemiological Classification.

Ocular immunology and inflammation
2025

Systemic Immunosuppression and Secondary Choroidal Neovascularisation in Patients with Punctate Inner Chorioretinopathy.

Ocular immunology and inflammation
2025

Ocular Insights: Exploring Uveitis as a Manifestation of Celiac Disease.

Cureus
2025

Clinical features, treatment and outcomes of dabrafenib-associated uveitis.

Investigational new drugs
2026

Relentless placoid chorioretinitis.

Survey of ophthalmology
2025

Sulfonamide Allergy and Alternative Treatments in Ocular Toxoplasmosis.

Romanian journal of ophthalmology
2025

Multizonal outer retinopathy and retinal pigment epitheliopathy (MORR) with a chronologically divergent presentation- a case report.

Journal of ophthalmic inflammation and infection
2025

Clinical outcomes of cyclophosphamide therapy in relentless placoid choroiditis: A descriptive case series.

Indian journal of ophthalmology
2025

Rapid contraction of the anterior capsule after phacoemulsification in uveitis: A case report.

Medicine
2025

Systematic Review of Clinical Utility of Multimodal Imaging in Noninfectious Posterior Uveitis: MUV Project Report 3.

American journal of ophthalmology
2025

Risk of uveitis in patients with human immunodeficiency virus: a cohort study through TriNetX database.

AIDS research and therapy
2025

Pediatric Noninfectious Intermediate, Posterior, and Panuveitis: A Review.

International ophthalmology clinics
2025

Drug-Induced Uveitis: Patterns, Pathogenesis and Clinical Implications.

Clinical optometry
2025

Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain.

International ophthalmology
2025

Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

Life (Basel, Switzerland)
2025

Evidence and Consensus-Based Imaging Guidelines in Noninfectious Posterior Uveitis-Methodology of the Multimodal Imaging in Uveitis (MUV) Project Report 2.

American journal of ophthalmology
2025

Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis.

Ophthalmology
2025

Incidence and Prevalence of Syphilitic Uveitis and Associated Ocular Complications in the TriNetX Database.

American journal of ophthalmology
2025

Infectious uveitis: Epidemiology, etiology, diagnostic test performance and treatment.

Archivos de la Sociedad Espanola de Oftalmologia
2025

Physician Burden and Time Delays in Initiating Immunomodulatory Therapy for Noninfectious Uveitis and Inflammatory Eye Diseases.

American journal of ophthalmology
2025

Uveitis in Adults: A Review.

JAMA
2025

Comparative Effectiveness of Intravenous versus Subcutaneous Tocilizumab for Refractory Uveitis: A Retrospective Analysis.

Ophthalmology
2025

Antigen-specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis.

Clinical &amp; translational immunology
2025

Uveitis associated with juvenile idiopathic arthritis (JIA) and JIA-like uveitis in pediatric patients.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
2025

Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis.

Ophthalmology. Retina
2025

Treatment outcomes of a Swiss non-infectious paediatric uveitis cohort: retrospective study over ten years.

Journal of ophthalmic inflammation and infection
2025

Programme for ocular inflammation & infection translational research (PROTON) registry: Cross-sectional analysis of baseline patient characteristics.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025

Optic disc pit: A trigger for secondary multiple evanescent white dot syndrome.

Retinal cases &amp; brief reports
2025

[Peripheral ulcerative keratitis with necrotizing scleritis, manifestation of granulomatosis with polyangiitis].

Revista medica del Instituto Mexicano del Seguro Social
2025

Atypical Presentation of Frosted Branch Angiitis due to Ocular Toxoplasmosis: A Case Report.

Ocular immunology and inflammation
2025

Active Juxtapapillary Toxoplasmic Retinochoroiditis Presenting with Henle Fiber Hemorrhages.

Ocular immunology and inflammation
2025

The clinical safety landscape for ocular AAV gene therapies: A systematic review and meta-analysis.

iScience
2025

Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period.

Diagnostics (Basel, Switzerland)
2025

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.

Journal for immunotherapy of cancer
2025

Occlusive Retinal Vasculitis After Aflibercept 8mg Injection for Wet Macular Degeneration.

Retinal cases &amp; brief reports
2025

Intravitreal Corticosteroids in the Management of Refractory Macular Edema in Birdshot Chorioretinopathy.

International medical case reports journal
2025

Occult invasive fungal sinusitis in a patient with acute Vogt-Koyanagi-Harada Disease (VKHD).

Retinal cases &amp; brief reports
2025

Cumulative incidence of macular edema in non-infectious uveitis indicates an early therapeutic window.

Acta ophthalmologica
2025

Inherited retinal disease-associated uveitis.

Survey of ophthalmology
2025

[Ten-year study of the epidemiology and clinical features of uveitis in Picardie, France].

Journal francais d'ophtalmologie
2025

BILATERAL SEQUENTIAL INFLAMMATORY FULL-THICKNESS MACULAR HOLES IN BIRDSHOT CHORIORETINOPATHY.

Retinal cases &amp; brief reports
2025

Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series.

Frontiers in pharmacology
2025

ROSAH syndrome presenting with recurrent vitreous hemorrhage: a multimodal imaging study.

Ophthalmic genetics
2025

Quantitative autofluorescence is increased in clinically unaffected fellow eyes from patients with posterior uveitis.

Scientific reports
2025

The Clinical Spectrum and Outcomes of Ocular Syphilis in Saudi Arabia: The Emergence of a Uveitic Masquerader.

Journal of epidemiology and global health
2025

Multiple evanescent white dot syndrome masquerading as atypical optic neuritis: a case report.

Journal of medical case reports
2025

Electrodiagnostic Tests as Potential Efficacy Endpoints in Clinical Trials of Novel Pharmacological Therapies for Acquired Retinal Disorders.

Ophthalmic research
2025

Polyol-modified deformable liposomes fortified contact lenses for improved ocular permeability.

Nanomedicine (London, England)
2025

Symptomatic Occlusive Retinal Vasculitis as an Unusual Presentation of Biopsy-Proven Sarcoidosis: A Case Series.

Ocular immunology and inflammation
2025

Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series.

Klinische Monatsblatter fur Augenheilkunde
2025

Delayed-Onset White-Dot Syndrome in the Setting of Traumatic Choroidal Rupture.

Journal of vitreoretinal diseases
2025

Trends in syphilis and syphilitic uveitis among South Korean adults in 2010-2019: a nationwide cohort study.

Sexually transmitted infections
2024

Posterior uveitis of syphilitic etiology.

Indian journal of sexually transmitted diseases and AIDS
2025

Clinical characteristics, treatment, and outcomes of nivolumab-induced uveitis.

Immunopharmacology and immunotoxicology
2025

Prospective International Registry for Treatment Exit Options in Uveitis (TOFU) - the First Five Years.

Klinische Monatsblatter fur Augenheilkunde
2025

Comparative evaluation of funduscopy, PCR and serology in the diagnosis of ocular toxoplasmosis at ECWA Eye Hospital, Kano.

BMJ open ophthalmology
2025

HLA-G Polymorphisms of The 3'-UTR Region Are Involved in Susceptibility to Non-Infectious Uveitis.

Ocular immunology and inflammation
2025

Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.

Survey of ophthalmology
2025

Acute macular neuroretinopathy occurrence in a Behçet disease patient: a case report.

Journal of ophthalmic inflammation and infection
2025

Demographic Features, Diagnoses and Real-World Clinical Management of Uveitis in Japan.

Ocular immunology and inflammation
2025

Spectrum of Imaging Characteristics of Birdshot Chorioretinopathy.

Ocular immunology and inflammation
2025

Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual Outcomes.

Eye (London, England)
2025

Unilateral vitritis in an immunocompetent individual - A rare presentation of ocular toxoplasmosis.

The Medical journal of Malaysia
2024

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review.

Diagnostics (Basel, Switzerland)
2025

INTRAOCULAR INFLAMMATION ASSOCIATED WITH FARICIMAB THERAPY: One-Year Real-World Outcomes.

Retina (Philadelphia, Pa.)
2025

Chorioretinitis Associated with HSV-1 Neuroinfection Following Viral Infection. A Case Report.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
2025

Inflammatory choroidal neovascularization: An evidence-based update.

Survey of ophthalmology
2024

Demography in Swiss paediatric uveitis: a retrospective cohort study.

Journal of ophthalmic inflammation and infection
2024

Targeting Oxidative Stress and Inflammation in the Eye: Insights from a New Model of Experimental Autoimmune Uveitis.

International journal of molecular sciences
2025

Pattern of Uveitis in Northern Vietnam.

Ocular immunology and inflammation
2024

Ocular findings in neurosyphilis: a retrospective study from 2012 to 2022.

Frontiers in neurology
2025

Pattern of Uveitis in a Tertiary Care Eye Hospital Setting in Pakistan: A Comprehensive Analysis.

Ocular immunology and inflammation
2025

Stage 1 Extensive Macular Atrophy with Pseudodrusen-Like Appearance Complicated by Multiple Evanescent White Dot Syndrome-Like Reaction.

Ocular immunology and inflammation
2025

Ocular manifestations of West Nile virus infection: A case report and systematic review of the literature.

European journal of ophthalmology
2025

Patterns and Outcomes of Pediatric Uveitis in a University-Based Tertiary Referral Center in Riyadh, Saudi Arabia.

Ocular immunology and inflammation
2024

Choroidal vasculitis as a biomarker of inflammation of the choroid. Indocyanine Green Angiography (ICGA) spearheading for diagnosis and follow-up, an imaging tutorial.

Journal of ophthalmic inflammation and infection
2024

Changing age pattern and diverse outcomes of herpes zoster ophthalmicus: exploring the temporal trend, decrease in incident age and influence of treatment strategies.

International ophthalmology
2025

Ocular infections in international travelers.

Travel medicine and infectious disease
2024

Posterior localized nodular scleritis mimicking malignancy, a case report and clinical approach.

Oxford medical case reports
2025

CMV-Related Hemorrhagic Retinal Vasculitis in a Multiple Myeloma Patient on Daratumumab Therapy: A Case Report.

Ocular immunology and inflammation
2024

Multimodal imaging findings of multiple evanescent white dot syndrome in COVID-19 patients.

IDCases
2024

"Infectious uveitis: a comprehensive systematic review of emerging trends and molecular pathogenesis using network analysis".

Journal of ophthalmic inflammation and infection
2024

Novel Plasma Kallikrein Inhibitors for Treating Multiple Diseases.

ACS medicinal chemistry letters
2025

Serpiginous Choroiditis After COVID-19 Infection.

Journal of vitreoretinal diseases
2025

Multimodal Imaging of a Unique Transitory Finding in Ocular Syphilis.

Journal of vitreoretinal diseases
2025

Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis.

Journal of vitreoretinal diseases
2025

Is it Time to Adopt a New Nomenclature and Classification for White Dot Syndromes Using Multimodal Imaging Techniques? Report 1 from Multimodal Imaging in Uveitis (MUV) Task Force.

Ocular immunology and inflammation
2024

Intraretinal hyperreflective line: potential biomarker in various retinal disorders.

Medical hypothesis, discovery &amp; innovation ophthalmology journal
2025

Review on the Use of Difluprednate in Inflammatory Eye Disorders: The Topical Steroid That Goes the Distance.

Ocular immunology and inflammation
2024

Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases.

Journal of ophthalmic inflammation and infection
2025

Brain MRI White Matter Abnormalities in Pediatric Non-Infectious Uveitis.

Ocular immunology and inflammation
2025

In Situ Crystallized Ceria-Vesicle Nanohybrid Therapeutic for Effective Treatment of Inflammatory Intraocular Disease.

Advanced healthcare materials
2024

Rheumatic diseases detected in patients presenting with uveitis.

Northern clinics of Istanbul
2025

Cystoid macular edema after low-energy femtosecond-assisted cataract surgery.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Ocular Syphilis: The Resurgence of an Old Disease Experience of a Tertiary Centre in Portugal.

Ocular immunology and inflammation
2024

Diffuse preretinal infiltrates in a patient with orbital atypical T-cell lymphoproliferative infiltration masquerading posterior uveitis.

GMS ophthalmology cases
2024

Tocilizumab for cystoid macular edema secondary to retinitis pigmentosa.

Journal of ophthalmic inflammation and infection
2024

Isolated Intraocular Jarisch-Herxheimer Reaction Following Treatment for Syphilitic Chorioretinitis.

Cureus
2024

Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis.

Frontiers in cellular neuroscience
2025

Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis.

Indian journal of ophthalmology
2025

Are Peripapillary Hyperreflective Ovoid Mass-like Structures with an Elevated Optic Disc Still a Diagnosis Dilemma?

Ophthalmology
2024

Recurrent ocular toxoplasmosis is associated with interferon-gamma deficiency possibly due to genetic origin.

BMJ open ophthalmology
2025

Intravitreal Antibiotics versus Early Vitrectomy Plus Intravitreal Antibiotics for Postinjection Endophthalmitis: An IRIS® (Intelligent Research in Sight Registry) Analysis.

Ophthalmology. Retina
2024

Unilateral Vogt-Koyanagi-Harada Disease With Two Distinct Choroidal Neovascular Membranes: A Case Report.

Cureus
2024

The Clue to Neurosarcoidosis Through Outer Retina: A Rare Case of Cavernous Sinus Sarcoidosis Uncovered Through Signs of Previous Posterior Uveitis.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

Human Ocular Toxoplasmosis in Romania: History, Epidemiology, and Public Health: A Narrative Review.

Microorganisms
2024

Categories and Profiles of Uveitis in Vogt-Koyanagi-Harada Syndrome With Systemic Correlation: Inferences From a Tertiary Multispecialty Hospital.

Cureus
2024

Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis.

Investigational new drugs
2025

De novo manifestations during adalimumab treatment in Behçet's syndrome.

Rheumatology (Oxford, England)
2024

Uveitis following COVID-19 vaccination in the pediatric population: Experience at a tertiary referral hospital.

Journal francais d'ophtalmologie
2025

Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at Baseline.

Ocular immunology and inflammation
2024

Bilateral Anterior Uveitis in the Context of Concurrent HIV and Syphilis Co-infection.

Cureus
2024

Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial.

JAMA ophthalmology
2024

Influence of gender on clinical presentation, management practices and outcomes of ocular syphilis.

Scientific reports
2024

Toxoplasmosis in the outer retina.

Romanian journal of ophthalmology
2024

Assessment of Blood Flow Velocity in Retinal Vasculitis Using the Retinal Function Imager-A Pilot Study.

Journal of clinical medicine
2025

Not Always Toxoplasmosis: Active Retinochoroiditis Presumably Secondary to Herpes in Eyes with Hyperpigmented Retinochoroidal Previous Scars.

Ocular immunology and inflammation
2024

Brief research report: ETS-1 blockade increases ICAM-1 expression in activated human retinal endothelial cells.

Frontiers in ophthalmology
2023

Role of interleukin 1β and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals.

Frontiers in ophthalmology
2025

The Spectrum of Presumed Tubercular Uveitis in a Referral Eye Clinic in Qatar.

Ocular immunology and inflammation
2024

Long-Term Outcomes of Scleral-Sutured Fixated Secondary Intraocular Lenses in Patients With Uveitis.

Ophthalmic surgery, lasers &amp; imaging retina
2026

Ocular Syphilis in Patients With Nonreactive Rapid Plasma Reagin and Positive Treponemal Serologies: A Retrospective Observational Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2025

Ocular Leptospirosis: Report of a Challenging Diagnosis.

Ocular immunology and inflammation
2025

Clinical Patterns of Sarcoidosis Patients with and without Uveitis: Insights from a Dutch Sarcoidosis Centre.

Ocular immunology and inflammation
2023

A Case of Ocular Sarcoidosis Post-COVID-19 Vaccination.

Cureus
2024

Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis.

Ocular oncology and pathology
2024

Label-Free Imaging of Inflammation at the Level of Single Cells in the Living Human Eye.

Ophthalmology science
2024

Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.

BMC ophthalmology
Ver todos os 372 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Uveíte posterior.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Uveíte posterior

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Are the SUN Criteria Sufficient for Tubercular Uveitis? Findings From a Multinational Registry Study.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41533901mais citado
  2. A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitis.
    International journal of pharmaceutics· 2026· PMID 41871672mais citado
  3. Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10.
    American journal of ophthalmology· 2026· PMID 41861898mais citado
  4. NON-INFECTIOUS POSTERIOR UVEITIDES - Atypicals, Variants, and Masquerades: the jungle of differential diagnosis.
    American journal of ophthalmology· 2026· PMID 41861897mais citado
  5. Combined PCR Positivity for Mycobacterium tuberculosis Complex and Nontuberculous Mycobacterium Species in Patients Treated for Tubercular Panuveitis.
    Ocular immunology and inflammation· 2026· PMID 41824922mais citado
  6. QuantiFERON-TB gold test: a valuable diagnostic tool for tubercular uveitis in non-endemic regions.
    Infection· 2026· PMID 41995793recente
  7. Characteristics of Uveitis in European Tertiary Ophthalmology Centers: A Systematic Review and Meta-Analysis.
    Ocul Immunol Inflamm· 2026· PMID 41994897recente
  8. Retinal pigment epithelium drives macrophage migration during Toxoplasma gondii infection in vitro.
    Mem Inst Oswaldo Cruz· 2026· PMID 41983790recente
  9. Immunoglobulin G4-Related Disease Manifesting as Posterior Uveitis.
    J Vitreoretin Dis· 2026· PMID 41929757recente
  10. Bilateral Multifocal Choroiditis in Polymyositis: A Case Report and Review of the Literature.
    Retin Cases Brief Rep· 2026· PMID 41922100recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:280892(Orphanet)
  2. MONDO:0001280(MONDO)
  3. GARD:4457(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q18554348(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Uveíte posterior
Compêndio · Raras BR

Uveíte posterior

ORPHA:280892 · MONDO:0001280
Prevalência
Unknown
Herança
Not applicable
Ensaios
7 ativos
Medicamentos
5 registrados
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0042167
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades